Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGIV-C for Corticosteroid Tapering in Generalized Myasthenia Gravis
NCT02473965Phase 2Completed
- Sponsor
- Grifols
- Start
- Jun 2015
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 2 trial of gamunex in myasthenia gravis (MG), sponsored by Grifols. Started Jun 2015; status: completed.
02
Drugs
gamunex
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT02473965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473965.